Skip to content
JLM-BioCity
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US
Menu Close
  • HOME
  • ABOUT US
    • What is JLM-BioCity?
    • What We Do
    • Board of Advisors
    • Meet the Team
  • EVENTS
    • Past Events
    • Event Clips
  • RESOURCES
    • JLM Bio Innovation
    • JLM Companies
    • JLM Landscape
    • BioTips
    • Blog
    • Briefs
  • JOIN US
    • Our Partners
    • Become a Partner
  • CONTACT US

JLM-BioCity Innovations

  1. Home>
  2. Resources>
  3. JLM-BioCity Innovations>
  4. Page 2

Myeloma Investment Fund Invests in KAHR’s Lead Immunotherapy Drug for Multiple Myeloma Treatment

November 28, 2022

The Myeloma Investment Fund (MIF), the Multiple Myeloma Research Foundation‘s (MMRF) venture philanthropy subsidiary, has invested in KAHR, a clinical-stage biotech company, to explore the

Read More »

Alpha Tau and MIM Software Are Collaborating On Alpha DaRT Treatment Planning

November 6, 2022

Jerusalem-based Alpha Tau Medical Ltd. (Nasdaq: DRTS) (“Alpha Tau“), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and MIM Software Inc. (“MIM Software”),

Read More »

Visit Image Navigation’s Latest Dental Surgical Navigational Systems at MIXiii BioConference in Jerusalem, Nov 9-10, 2022

November 6, 2022

Image Navigation Ltd., a pioneer in surgical navigation systems, will present their second generation Image Guided Implantology (IGI) system at the Jerusalem Ecosystem Booth at

Read More »

Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine

October 31, 2022

Immunyx Pharma is member of CanceRNA , a global consortium applying RNA-based therapeutics to successfully unlock anti-cancer immune responses. The consortium is led by Professor

Read More »

Positive Preliminary Phase 1 Data for Oramed Subsidiary Oravax’s Oral Covid-19 Vaccine

October 13, 2022

Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that its

Read More »

Mirror Biologics, Inc. Closes Out $30M Series A Investment Round with Additional $20M

October 11, 2022

Mirror Biologics, Inc., a clinical-stage biopharmaceutical company today announced the completion of the final $20 million tranche of its $30 million Series A investment round

Read More »

Breakthrough RNA-Based Cancer Immunotherapy Being Developed by Global Consortium led by Hadassah Cancer Research Inst

October 10, 2022

Pharmaceutical company Merck and Hadassah University Hospital in Jerusalem launched CanceRNA, which aims to use messenger-RNA technology to treat cancer. CanceRNA,  a global consortium that

Read More »

Image Navigation To Launch World’s Most Advanced Image Guided Dental Implant Technology

September 28, 2022

Jerusalem-based Image Navigation Ltd., a pioneer in surgical navigation systems, plans to launch its second generation Image Guided Implantology (IGI) system during the EAO Congress

Read More »

Positive Top-Line Results from Oramed’s Oral Insulin Drug Phase 2 NASH Trial

September 21, 2022

Oramed Pharmaceuticals Inc. ( Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced today positive

Read More »
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Next »

JLM-BioCity Upcoming Events

More JLM-BioCity events coming soon…

What People Say About JLM-BioCity

Alexander Naslednikov

JLM-BioCity Member Alexander Naslednikov

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

-Alexander Naslednikov, Founder and CEO, Med.me

Tal Or

JLM-BioCity Member Tal Or

One of the best meetups organizations and a very important source of information and connections for startups.

-Tal Or, Co-Founder, ATLASense Biomed Ltd.

Hemda Idel

JLM BioCity Member Hemda Idel

Very informative and eye-opening event. Thank you for the great hospitality.

– Hemda Idel, founder, SLEEP ASAP

Aviv Marom

JLM BioCity Member Aviv Marom

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

-Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Aurélie Schwarzbach

Such an interesting lecture and great people attending!

– Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Zeev Malyutin

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

– Zeev Malyutin, Protein Department Head, Merck KGaA

Gideon Silberman

JLM BioCity Member Gideon Silberman

Excellent event. Good speakers, interesting audience. Well done!

– Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Immanuel Lerner

Immanuel Lerner CEO, Pepticom

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

– Immanuel Lerner CEO, Pepticom

Dror Chevion

Dror Chevion Concenter BioPharma

JLM-BioCity’s events are well organized with a professional approach. You can feel a “homey” atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

– Dror Chevion  CEO, Concenter BioPharma

Ian Solomon

Ian Solomon CTO, OmnySense Ltd

The JLM BioCity networking events on Zoom keeps getting better.  For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

-Ian Solomon CTO, OmnySense Ltd.

Moshe Lebowitz

Moshe Lebowitz with Jerusalem Mayor Moshe Leon - Credit Dr George Lowell

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

– Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

JLM-BioCity in THE MARKER

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

Strategic Partners

Platinum

Gold

Silver

JLM-BIOCITY is a division of the Jerusalem Business Networking Forum (JBNF)

Contact us at

+972-(0)54-973-0029

info at jlm-biocity.org

Follow us

Linkedin Facebook-f Youtube

Home

About

What’s Happening

Resources

Become a Partner

Become a Member

JLM-BioSynergy

Contact Us

Copyright © 2020 JLM-BioCity | All rights reserved